Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:7974
TSE:7974Entertainment

Is Nintendo (TSE:7974) Fairly Priced After Recent Share Price Swings?

Wondering whether Nintendo's share price reflects its true value today, or if the market is missing something that you could be early to? The stock recently closed at ¥9,215, with a 5.5% gain over the last 30 days, although returns sit at a 13.5% decline year to date and a 14.7% decline over the last year, set against an 87.7% gain over 3 years and 63.7% over 5 years. Recent coverage has focused on how Nintendo fits into the broader entertainment and gaming sector, including discussion of...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

A Look At SolarEdge (SEDG) Valuation After Nexis Launch Targets German Residential Solar Market

Why SolarEdge’s Nexis Launch in Germany Has Investors Watching the Stock SolarEdge Technologies (SEDG) has drawn fresh investor attention after launching its three phase Nexis residential solar and storage system in Germany, pairing higher power inverters with modular batteries and faster installation. See our latest analysis for SolarEdge Technologies. Beyond the Nexis launch, investors have also been reacting to a J.P. Morgan webinar on SolarEdge’s role in power infrastructure for AI. The...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Coinbase Mortgage Partnership Tests Crypto Utility Beyond Trading Revenue Cycles

Coinbase Global (NasdaqGS:COIN) has partnered with Better Home & Finance to let U.S. homebuyers use Bitcoin or USDC as collateral for mortgage down payments. The product is designed for federally backed conforming loans and allows borrowers to keep their crypto holdings instead of selling them to fund a purchase. The structure includes protections such as no margin calls, aiming to make crypto backed mortgages more predictable for homeowners. Coinbase Global, trading at around $161.14, has...
NYSE:AWK
NYSE:AWKWater Utilities

How Investors May Respond To American Water Works (AWK) Officer Exculpation And New Infrastructure Upgrades

In March 2026, American Water Works Company’s board approved amendments to its Restated Certificate of Incorporation to extend Delaware-permitted liability exculpation to officers, while subsidiaries announced more than US$2.21 million of water main upgrades in Kentucky and West Virginia to replace aging infrastructure and improve service reliability. These developments come as an industry report projects US$2.10–US$2.40 trillion in U.S. drinking water investment needs over 25 years,...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Assessing AST SpaceMobile (ASTS) Valuation After New BlueBird Launches And US$30 Million Government Contract

AST SpaceMobile (ASTS) has been back in focus after launching new BlueBird satellites, including Bluebird 6 with a large communications-array antenna in low Earth orbit, funded by fresh capital and reinforced by a new US$30 million government contract. See our latest analysis for AST SpaceMobile. Despite a sharp 10.46% 1 day share price decline and a softer 1 month share price return, AST SpaceMobile still carries a strong 1 year total shareholder return of 226.97%. This suggests sentiment...
NasdaqGS:APLD
NasdaqGS:APLDIT

Applied Digital Spin Off Of Cloud Unit Raises New Risk Reward Questions

Applied Digital (NasdaqGS:APLD) plans to spin off its cloud computing business and merge it with EKSO Bionics Holdings to form a new company called ChronoScale. The transaction will separate Applied Digital's cloud assets from its remaining operations, which focus on digital infrastructure and high performance computing leasing. The move is intended to reshape the business mix and could affect Applied Digital's margins, revenue profile, and risk exposure once completed. For investors...
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

Assessing Xenon Pharmaceuticals (XENE) Valuation After Positive Phase 3 Results And US$750 Million Capital Raise

Xenon Pharmaceuticals (NasdaqGM:XENE) drew investor attention after reporting positive topline Phase 3 results for its lead drug candidate, azetukalner, followed by an upsized public offering that raised nearly US$750 million. See our latest analysis for Xenon Pharmaceuticals. At a share price of US$54.48, Xenon has given investors a 22.22% 1 month share price return and a 59.02% 1 year total shareholder return. This suggests momentum has picked up around the Phase 3 readout and capital...
BME:ITX
BME:ITXSpecialty Retail

Assessing Inditex (BME:ITX) Valuation After Recent Share Price Pullback

Recent share performance and business scale Industria de Diseño Textil (BME:ITX) has drawn attention after a recent share price pullback, with the stock down about 2% over the past week and roughly 13% over the past month. This move comes against a backdrop of sizeable scale, with annual revenue of €39.864b and net income of €6.220b, and operations spanning Spain, the rest of Europe, the Americas, Asia and other international markets. See our latest analysis for Industria de Diseño...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Is Ark Invest’s Steady Buying Reframing the Long-Term Product Expansion Story At 10x Genomics (TXG)?

Cathie Wood’s Ark Invest recently added to its position in 10x Genomics over four consecutive trading sessions, highlighting renewed institutional interest in the life sciences tools maker and its single-cell Chromium platform. This persistent buying streak by a high-profile investor brings additional attention to 10x Genomics’ role in advanced genomics workflows, potentially influencing how other market participants view its long-term demand outlook. We’ll now examine how Cathie Wood’s...
TSX:BTO
TSX:BTOMetals and Mining

Assessing B2Gold (TSX:BTO) Valuation After Encouraging Back River Exploration Results

B2Gold (TSX:BTO) has put fresh exploration results from its Back River Gold District program in Nunavut at center stage, with new drilling at the Goose Mine Llama and Nuvuyak deposits confirming extensive high grade mineralization. See our latest analysis for B2Gold. The latest Back River results land at a time when B2Gold’s share price has shown mixed momentum, with a 9.28% 7 day share price return but a 30.38% 30 day share price decline, while the 1 year total shareholder return of 44.58%...
NYSE:GAP
NYSE:GAPSpecialty Retail

Gap (GPS) Valuation Check As China Breakthrough And AI Push Gain Traction

Why Gap’s latest China push and AI rollout matter now Gap (GAP) is back in focus after hitting breakeven in China under Baozun. The company is outlining plans for 50 new mainland stores and Hong Kong reopenings, while rolling out new AI tools and a Google commerce partnership. See our latest analysis for Gap. Despite the China expansion plans and fresh AI partnerships, recent share price momentum has been mixed, with a 7 day share price return of 3.47% but a 30 day share price return of 8.98%...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Does Braze (BRZE) Pairing Buybacks With New Share Issuance Clarify Its Capital Allocation Priorities?

Braze, Inc. recently reported past fourth-quarter and full-year results showing higher sales and a wider net loss, issued revenue guidance for fiscal 2027, authorized a US$100 million share repurchase program, and filed a US$121.93 million shelf registration for 6,766,238 Class A shares tied to an ESOP offering. While Braze is still loss-making, management is guiding to higher revenue and planning to return capital via buybacks even as new shares are registered for potential issuance. With...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Precigen (PGEN) Is Up 11.9% After PAPZIMEOS’ Launch Shifts Focus Toward Commercial Revenue Model

For the full year 2025, Precigen, Inc. reported revenue of US$9.68 million compared to US$3.93 million in 2024, while net loss widened to US$250.64 million and loss per share from continuing operations increased to US$1.37. Despite the larger loss, Precigen’s first FDA-approved therapy PAPZIMEOS for adult recurrent respiratory papillomatosis, broad label, emerging standard-of-care status, and upcoming permanent J-code together mark a shift toward a commercial revenue model with growing...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash Foot Locker Deal Expands Retail Reach And Sparks Valuation Questions

DoorDash (NasdaqGS:DASH) has launched a retail partnership with Foot Locker, Kids Foot Locker, and Champs Sports. The agreement brings on-demand access to footwear and apparel from nearly 1,300 U.S. store locations through the DoorDash marketplace. The collaboration extends DoorDash’s reach beyond food and grocery into sportswear and athletic apparel delivery. For DoorDash, this move broadens an already large on demand platform into a wider retail role, giving consumers a way to order...
SEHK:488
SEHK:488Real Estate

Lai Sun Development (SEHK:488) H1 2026 Loss Deepens To HK$1.90 EPS Loss Challenges Bulls

Lai Sun Development (SEHK:488) has reported its H1 2026 results with revenue of HK$2.4 billion and a basic EPS loss of HK$1.90, alongside a net loss excluding extra items of HK$2.8 billion, as the group continues to work through a difficult earnings patch. Over recent periods the company has seen revenue move from HK$3.0 billion and a basic EPS loss of HK$1.25 in H2 2024 to HK$2.5 billion and a basic EPS loss of HK$0.08 in H1 2025, then to HK$2.4 billion and a basic EPS loss of HK$1.90 in H2...